If you are looking for some exposure to the small side of the market, then it could be worth hearing what the team at Securities Vault is saying, courtesy of The Bull.
It has just given its verdict on several small-cap ASX shares. Here's what it is recommending:
Image source: Getty Images
Mach7 Technologies Ltd (ASX: M7T)
Securities Vault has named Mach7 as a small-cap ASX share to buy.
It believes the enterprise imaging platform provider is well-placed to grow its recurring revenue thanks to expanding budgets in the US healthcare sector. It explains:
The company provides enterprise imaging platforms used by hospitals across the globe, positioning it as a scalable SaaS (software-as-a-service) style health technology play. Recent quarterly updates have shown improving cost discipline and operating leverage. The real upside lies in recurring revenue growth and contract wins across North America, where healthcare information technology budgets are structurally expanding.
As hospitals modernise legacy systems, Mach7's vendor-neutral archive (VNA) offering becomes increasingly relevant. If management continues to convert its pipeline into contracts, the market could materially re-rate earnings visibility. At current levels, it still trades at a discount to global peers despite similar growth characteristics.
Oneview Healthcare (ASX: ONE)
Another small-cap ASX share that Securities Vault rates as a buy is Oneview Healthcare.
It is feeling positive about the care experience platform provider's outlook due to favourable funding tailwinds in the US market. It explains:
Its care experience platform integrates patient engagement tools into hospital systems. The company's offering should generate demand. Potential upside exits following positive momentum. The investment thesis hinges on hospital digitisation and patient experience mandates, particularly in the US, where funding tailwinds remain supportive.
As deployments scale up, Oneview's recurring revenue model should drive operating leverage. Importantly, the company has already secured major hospital clients, reducing execution risk compared to earlier stage peers.
WRKR Ltd (ASX: WRK)
One small-cap ASX share that Securities Vault isn't positive on is WRKR. It has named the workforce compliance and payroll solutions company's shares as a sell this week.
Securities Vault has concerns over elevated execution risks and an uncertain pathway to profitability. It explains:
The company operates in workforce compliance and payroll solutions—an attractive theme—but execution risk remains elevated, in our view. Despite operating in a growing sector, the pathway to profitability remains uncertain. The company posted a loss after tax of $2.66 million in the first half of 2026. Investors chasing the theme may be better served in bigger, more established platforms offering stronger execution capabilities.
